| |
| |
|
| Insider
Information: |
Hayden Donald J Jr |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
278,741 |
|
|
Indirect Shares
|
4,869 |
|
|
| Direct
Value |
$11,041,378 |
|
|
|
Indirect Value
|
$218,813 |
|
|
| Total
Shares |
283,610 |
|
|
| Total
Value |
$11,260,191 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP and President, Ame... |
2005-03-01 |
207,649 |
2005-03-01 |
4,869 |
Premium* |
|
|
Insmed Inc |
INSM |
Director |
2019-04-09 |
62,197 |
2011-03-24 |
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2016-03-21 |
0 |
2015-05-20 |
0 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
Director |
2018-06-07 |
8,895 |
2015-06-23 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2020-02-10 |
0 |
2015-09-22 |
0 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
Director |
2024-02-14 |
0 |
2022-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2015-05-20 |
4 |
S |
$12.01 |
$240,200 |
D/D |
(20,000) |
0 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2015-06-23 |
4 |
AS |
$14.01 |
$770,391 |
D/D |
(55,000) |
0 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2015-09-21 |
4 |
AS |
$17.00 |
$274,210 |
D/D |
(16,130) |
0 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2015-12-29 |
4 |
AS |
$18.00 |
$290,340 |
D/D |
(16,130) |
0 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2016-03-21 |
4 |
AS |
$7.42 |
$119,685 |
D/D |
(16,130) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Director |
– • – |
2017-05-15 |
4 |
AS |
$19.04 |
$163,725 |
D/D |
(8,599) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2017-09-05 |
4 |
AS |
$24.95 |
$499,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2017-09-15 |
4 |
AS |
$27.45 |
$549,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2017-09-18 |
4 |
AS |
$29.95 |
$599,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2017-09-27 |
4 |
AS |
$32.45 |
$649,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2017-10-11 |
4 |
AS |
$34.95 |
$699,000 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-05-09 |
4 |
AS |
$45.00 |
$675,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-05-14 |
4 |
AS |
$50.04 |
$257,856 |
D/D |
(5,153) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-05-15 |
4 |
AS |
$50.06 |
$492,941 |
D/D |
(9,847) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-06-01 |
4 |
AS |
$55.00 |
$5,500 |
D/D |
(100) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-06-05 |
4 |
AS |
$55.01 |
$819,649 |
D/D |
(14,900) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2020-01-14 |
4 |
AS |
$45.60 |
$1,368,000 |
D/D |
(30,000) |
0 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2020-02-05 |
4 |
AS |
$50.00 |
$100,000 |
D/D |
(2,000) |
0 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2020-02-10 |
4 |
AS |
$50.11 |
$1,242,728 |
D/D |
(24,800) |
0 |
0 |
% |
|
| THRX |
Theseus Pharmaceuticals, ... |
Director |
– • – |
2024-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-06-01 |
4 |
OE |
$0.85 |
$85 |
D/D |
100 |
100 |
0 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
Director |
– • – |
2022-12-29 |
4 |
B |
$5.00 |
$500 |
D/D |
100 |
100 |
2.31 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2020-02-05 |
4 |
OE |
$0.85 |
$1,700 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2018-05-14 |
4 |
OE |
$0.85 |
$4,380 |
D/D |
5,153 |
5,153 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,814 |
5,814 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
